John Aucott, M.D. Presents to NatCapLyme
October 11, 2015, 2:00 PM - 4:00 PM
Johns Hopkins Sibley Memorial Hospital
Washington, DC United States
Lyme disease now afflicts more than 300,000 people per year, making it the fastest growing vector-borne disease in the U.S. Dr. Aucott is a renowned expert in clinical research on the diagnosis and epidemiology of Lyme disease. He has spent more than a decade studying the disease’s potentially crippling effects. As director of the Lyme Disease Clinical Research Center, housed in the rheumatology division of John Hopkins Bayview Medical Center, Dr. Aucott has received an initial grant to lead the first prospective controlled study in the U.S. to examine the impact of Lyme disease on patients’ immune systems and their long-term health.
Known as SLICE (Study of Lyme Disease Immunology and Clinical Events), the study aims to understand why some patients develop post-treatment Lyme disease syndrome, or chronic Lyme, lasting months or years, while others do not. Some doctors call persistent symptoms post-treatment Lyme disease (PTLDS) while others call it chronic Lyme. According to Dr. Aucott, “These patients with long-term Lyme are lost. No one knows how to deal with them. It’s a challenge but the first thing we need to do is recognize there is a problem. There is not a magic pill. These people already got the magic pill and it didn’t work.” Presently, Dr. Aucott has expanded his study to include a cross-sectional study of chronic Lyme disease patients with a focus on post-treatment Lyme disease syndrome. Dr. Aucott is also a practicing clinician at Park Medical Associates and part of the teaching faculty at Johns Hopkins School of Medicine.
RSVP: Seating is limited
Call: 703.821.8833 or email: email@example.com to reserve a seat.